GateNet
Flow cytometry is a widely utilized technique for identifying cell populations in patient-derived fluids, such as peripheral blood (PB) or cerebrospinal fluid (CSF). Despite its prevalence in research and clinical practice, flow cytometry involves a manual gating process for cell type identification, which is labor-intensive and prone to errors. The need for automated solutions to streamline this process has led to the development of GateNet, a novel neural network architecture designed to enable end-to-end automated gating without the necessity for correcting batch effects.
Research Project
GateNet is trained using an extensive dataset comprising over 8,000,000 events from N=127 PB and CSF samples, manually labeled independently by four experts. The neural network achieves human-level performance on novel, unseen samples, with an F1 score ranging from 0.910 to 0.997. The robustness of GateNet is further demonstrated by its application to a publicly available dataset, where it exhibits a F1 score of 0.936, confirming its generalization capabilities.
A notable feature of GateNet is its efficient processing, requiring only 15 microseconds per event, thanks to implementation on graphics processing units (GPU). Moreover, the study highlights that GateNet attains human-level performance with as few as ~10 samples, making it widely applicable across various domains of flow cytometry.
In summary, GateNet represents a significant advancement in the field of flow cytometry by providing a fully automated gating solution. Its ability to achieve human-level performance, efficient processing, and generalization across datasets positions it as a valuable tool for improving the accuracy and efficiency of cell type identification in diverse applications of flow cytometry.
Related Posts
Intraepidermal Nerve Fiber Density Quantification
In collaboration with the Institute for Neuropathology at the University of Münster, we are developing a standardized method for quantifying the degree of innervation of a patient’s skin, supporting the research of exposure to gadolinium-based contrast-agents by Prof.
Read More